Neuronetics Stock Price

0.28 (6.35%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 194,602
Bid Price 3.75
Ask Price 5.95
News (3)
Day High 4.67


52 Week Range


Day Low 4.3701
Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
Canadian Level 1 + USA
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Neuronetics Inc STIM NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.28 6.35% 4.69 00:00:00
Open Price Low Price High Price Close Price Prev Close
4.45 4.3701 4.67 4.66 4.41
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
1,970 194,602 $ 4.51 $ 876,700 - 1.98 - 9.07
Last Trade Time Type Quantity Stock Price Currency
19:59:43 90 $ 4.60 USD


Draw Mode:

Neuronetics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 126.74M 27.02M 23.55M $ 55.31M $ -34.54M -1.19 -3.10
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 521.49k 11.90%

more financials information »

Neuronetics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical STIM Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week4.054.673.874.28329,3850.6415.8%
1 Month3.634.673.293.821,620,1571.0629.2%
3 Months2.284.672.20013.69712,0902.41105.7%
6 Months3.274.671.983.41467,9421.4243.43%
1 Year7.819.071.984.40399,984-3.12-39.95%
3 Years11.1022.431.256.56401,319-6.41-57.75%
5 Years25.0039.391.257.92327,512-20.31-81.24%

Neuronetics Description

Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now